OTC Healthcare Drug Manufacturers - Specialty & Generic SDZNY

Sandoz Group AG

$ 84.32 -1.39 %

Sandoz Group AG operates as a global pharmaceutical enterprise, primarily focusing on the development, manufacturing, and commercialization of generic medicines and biosimilars. Their offerings include finished dosage forms of small molecule pharmaceuticals, often supplied to other businesses. Additionally, the company provides protein-based and other biotechnology-derived products, along with specialized biotechnology manufacturing services. Sandoz also produces anti-infective compounds, specifically active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

CEO: Richard Saynor - https://www.sandoz.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

Hold

DCF

$ 10.37

Loading data...

SDZNY vs S&P500

Loading data...

No data available.

Quick ratio

0.77

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

40.34

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

2.09

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

10.09 %

reflects reasonable profitability, showing good use of equity.

ROIC

7.81 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

6.17

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.61

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

1.88

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

34.29 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
6 indicates moderate financial health
Altman score
3.06 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.25 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.26 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.